Glenmark Pharmaceuticals has informed about a Press Release dated , titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Lacosamide Tablets, 50 mg, 100 mg, 150 mg and 200 mg’.
The above information is a part of company’s filings submitted to BSE.